Innate Pharma S.A. - Price History
Monthly price history for IPHA (Innate Pharma S.A.)
Date | Adjusted price | Real price |
---|---|---|
May 2024 | $2.48 | $2.48 |
April 2024 | $2.31 | $2.31 |
March 2024 | $2.88 | $2.88 |
February 2024 | $2.62 | $2.62 |
January 2024 | $2.68 | $2.68 |
December 2023 | $2.80 | $2.80 |
November 2023 | $2.40 | $2.40 |
October 2023 | $2.47 | $2.47 |
September 2023 | $2.53 | $2.53 |
August 2023 | $2.91 | $2.91 |
July 2023 | $2.94 | $2.94 |
June 2023 | $3.08 | $3.08 |
May 2023 | $2.94 | $2.94 |
April 2023 | $2.95 | $2.95 |
March 2023 | $2.85 | $2.85 |
February 2023 | $2.95 | $2.95 |
January 2023 | $3.44 | $3.44 |
December 2022 | $3.73 | $3.73 |
November 2022 | $2.15 | $2.15 |
October 2022 | $2.15 | $2.15 |
September 2022 | $2 | $2 |
August 2022 | $2.68 | $2.68 |
July 2022 | $3.20 | $3.20 |
June 2022 | $2.70 | $2.70 |
May 2022 | $2.66 | $2.66 |
April 2022 | $2.87 | $2.87 |
March 2022 | $3.36 | $3.36 |
February 2022 | $3.41 | $3.41 |
January 2022 | $3.79 | $3.79 |
December 2021 | $4.56 | $4.56 |
November 2021 | $4.96 | $4.96 |
October 2021 | $5.80 | $5.80 |
September 2021 | $6.17 | $6.17 |
August 2021 | $3.64 | $3.64 |
July 2021 | $3.32 | $3.32 |
June 2021 | $3.29 | $3.29 |
May 2021 | $3.91 | $3.91 |
April 2021 | $4.24 | $4.24 |
March 2021 | $4.31 | $4.31 |
February 2021 | $4.59 | $4.59 |
January 2021 | $4.09 | $4.09 |
December 2020 | $4.09 | $4.09 |
November 2020 | $5.34 | $5.34 |
October 2020 | $4.39 | $4.39 |
September 2020 | $3.84 | $3.84 |
August 2020 | $6.21 | $6.21 |
July 2020 | $6.08 | $6.08 |
June 2020 | $6.85 | $6.85 |
May 2020 | $6.50 | $6.50 |
April 2020 | $7.60 | $7.60 |
March 2020 | $6.68 | $6.68 |
February 2020 | $6.26 | $6.26 |
January 2020 | $7.02 | $7.02 |
December 2019 | $6.44 | $6.44 |
November 2019 | $6.28 | $6.28 |
October 2019 | $5.95 | $5.95 |
IPHA
Price: $2.48
52 week price:
Earnings Per Share: -0.10 USD
P/E Ratio: -3.06
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 6529
Market Capitalization: 205.8 million